Atezolizumab/Vaccine Combo May Show Long-Term Survival in ES-SCLC

Combining dendritic cell (DC) vaccination with atezolizumab (Tecentriq) produced long-term survival in a small cohort of patients with extensive-stage small cell lung cancer (ES-SCLC), according to findings from a phase 1b/2 trial (NCT04487756)…